Welcome to our dedicated page for Check Cap SEC filings (Ticker: CHEK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Check-Cap Ltd. (NASDAQ: CHEK) SEC filings page on Stock Titan aggregates the company’s U.S. regulatory disclosures, offering investors direct access to official information about its business, strategic transactions and compliance status. As a foreign private issuer, Check-Cap files annual reports on Form 20-F and furnishes current reports on Form 6-K, which are frequently incorporated by reference into its registration statements on Form F-3 and Form S-8.
Recent Form 6-K filings detail the company’s transformational merger with MBody AI Corp., a Nevada-based embodied artificial intelligence company. These reports include the Agreement and Plan of Merger, shareholder meeting results approving the merger and related proposals, and a proposal to change the company’s name to “MBody AI Ltd.” at the effective time of the transaction. Other 6-Ks describe Nasdaq correspondence on listing requirements, including minimum bid price, stockholders’ equity and periodic filing obligations, as well as the company’s responses and subsequent compliance updates.
Filings also document Check-Cap’s acquisition of exclusive Ghost Kitchen franchise rights in New Jersey through an Asset Purchase Agreement, outlining the consideration paid in ordinary shares and the revenue-sharing structure for franchise fees and royalties. Historical disclosures provide background on Check-Cap’s legacy medical diagnostics business, including its C-Scan® investigational device for colorectal cancer screening and related intellectual property.
On Stock Titan, these filings are supplemented by AI-powered summaries that explain the key points of lengthy documents, helping readers interpret complex legal and financial language. Investors can review annual reports (Form 20-F) for a comprehensive discussion of operations and risk factors, and use current reports (Form 6-K) to track material events such as mergers, financing plans, Nasdaq communications and significant business updates. Together, the CHEK filings offer a detailed regulatory record of the company’s shift from medical diagnostics toward embodied AI and automation.
Check-Cap Ltd. files a Prospectus Supplement registering up to 2,267,857 Ordinary Shares as part of its existing prospectus dated February 23, 2026. This supplement incorporates by reference a Form 6-K furnished February 24, 2026 and updates the Registration Statement on Form F-1.
The attached Form 6-K states that MBody AI Corp. has submitted a Nasdaq listing application, described as a regulatory milestone toward closing the previously announced merger with Check-Cap, which the companies target to close in the first half of 2026, subject to customary closing conditions. The press release also notes a $30M growth facility is available. The supplement must be read with the Prospectus and Risk Factors referenced therein.
Check-Cap Ltd. reported that MBody AI Corp. has submitted its Nasdaq listing application, marking a significant regulatory step toward completing their previously announced merger. The application advances plans for the combined company to trade on the Nasdaq Capital Market in the first half of 2026, subject to customary closing conditions.
The update follows several recent milestones, including Check-Cap’s regaining compliance with Nasdaq’s continued listing requirements, filing a Form F-1 related to an equity line of credit with ARC Group International Inc., and completion of MBody AI’s audited financial statements. The companies also highlight a $30M growth facility
Check-Cap Ltd. is registering for resale
The shares relate to a Purchase Agreement dated
As context, there were 7,288,359 Ordinary Shares outstanding as of January 29, 2026. The Purchase Agreement contains ownership limits including a 9.99% beneficial ownership cap for the Selling Shareholder and an Exchange Cap of 19.99% of outstanding Ordinary Shares as of the Purchase Agreement date, subject to shareholder approval or Nasdaq exception.
Check-Cap Ltd. is registering up to 2,267,857 ordinary shares for resale by ARC Group International under a three-year equity purchase agreement. The registration covers 2,000,000 advance shares at an assumed $1.89 per share plus 267,857 commitment fee shares issued as consideration.
Check-Cap will not receive proceeds from ARC Group’s resales, but may raise up to $30.0 million by selling shares to ARC under the agreement, subject to pricing formulas, a 9.99% ownership cap and Nasdaq rules. There were 7,288,359 ordinary shares outstanding as of January 29, 2026. The filing also describes a pending merger with MBody AI, after which MBody AI holders are expected to own 90% of the combined company.
Check-Cap Ltd. is registering 2,267,857 Ordinary Shares for resale by ARC Group International Ltd. under a three-year share purchase agreement. The registration covers 2,000,000 shares that may be issued as advances and 267,857 already-issued commitment fee shares.
Check-Cap will not sell shares under this prospectus, but may raise up to
Check-Cap Ltd. furnishes a Form 6-K with audited financial statements for merger target MBody AI Corp. and unaudited pro forma combined financial information as they work toward closing a previously approved merger. Check-Cap and MBody AI expect the merger to complete in the first half of 2026, but note it depends on satisfying closing conditions, including sufficient capital to meet Nasdaq listing requirements and completion of regulatory and exchange reviews. MBody AI, formed in October 2024, reported total net revenue of $93,775 and a net loss of $56,503 for the six months ended June 30, 2025, with cash of $568,876 and loans payable to shareholders and related parties of $173,202 as of that date.
Check-Cap Ltd. reports that it has regained compliance with Nasdaq’s minimum shareholders’ equity requirement under Listing Rule 5550(b) for continued listing on The Nasdaq Capital Market. Nasdaq’s written confirmation removes a key regulatory hurdle as the company advances its previously announced, shareholder-approved merger with MBody AI. The merger, which received approximately 98% shareholder approval in November 2025, is described as remaining on track and is expected to transform Check-Cap into a publicly traded embodied artificial intelligence company, subject to customary closing conditions.
Check-Cap Ltd. (CHEK) reports that, based on its unaudited financial statements for the six months ended June 30, 2025, its stockholders’ equity now exceeds the
The company had previously fully impaired a loan receivable from Apollo Technology Capital Corporation, but after receiving new information about Apollo’s financial condition, it reinstated the recoverable portion of that loan when preparing its June 30, 2025 financials. This reinstatement increased stockholders’ equity above the Nasdaq threshold, and the company believes it is currently in compliance with the equity listing rule.
Nasdaq will continue to monitor ongoing compliance, and the company notes that failure to meet the equity rule or other listing requirements in future periodic reports could lead to delisting, though it anticipates being in compliance at the time of its next filing.
Check-Cap Ltd. submitted a Form 6-K to furnish its consolidated unaudited financial statements as of and for the six months ended June 30, 2025. These interim results are provided as Exhibit 99.1, along with related Inline XBRL data files. The filing also states that this report is incorporated by reference into Check-Cap’s existing registration statements on Form F-3 and Form S-8, meaning those shelf and equity compensation registrations now also cover the information in these latest financial statements.
Check-Cap Ltd. furnished a Form 6-K that is incorporated by reference into its existing shelf registration on Form F-3 and multiple Form S-8 employee share plans, meaning this update becomes part of those registration statements from the submission date unless later superseded. The company reports that it held its Annual General Meeting of Shareholders on November 14, 2025, where shareholders approved the proposals on the agenda by the requisite majority under Israeli Companies Law. The report is signed on behalf of the company by Interim Chief Executive Officer David Lontini.